Evidence map›Paper›PMID 20147293›Full record

ArticleThe Journal of biological chemistry2010

Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.

Kyoo-Young Lee, Kailin Yang, Martin A Cohn, Nilabja Sikdar, Alan D D'Andrea, Kyungjae Myung

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kyoo-Young LeeGenome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Kailin Yang
Martin A Cohn
Nilabja Sikdar
Alan D D'Andrea
Kyungjae Myung
Harvard University · USNational Human Genome Research Institute · USDana-Farber Cancer Institute · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Gregory L Hura · 2001 to 2026
$89.6M
Systematic in vivo characterization of disease-associated regulatory variantsUM1HG012003 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael Isaiah Love, KAREN L. MOHLKE · 2021 to 2026
$9.9M
Genome Instability in Cancer DevelopmentZIAHG012003 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MYUNG, KYUNGJAE · 2009 to 2015
$7.0M
MOLECULAR PATHOGENESIS OF FANCONI ANEMIAR01HL052725 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI ALAN D. D'ANDREA · 1994 to 2026
$5.9M
STRUCTURE AND FUNCTION OF THE ERYTHROPOIETIN RECEPTORR01DK043889 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 1992 to 2014
$5.3M
Genome Instability in Cancer DevelopmentZ01HG012003 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MYUNG, KYUNGJAE · 2003 to 2008
$3.0M
Intramural NIH HHS Z01 HG012003NCI NIH HHS P01 CA092584NCI NIH HHS P01-CA092584NHGRI NIH HHS UM1 HG012003NHLBI NIH HHS R01 HL052725NHLBI NIH HHS R01-HL52725NIDDK NIH HHS R01 DK043889NIDDK NIH HHS R01-DK43889
6 · The paper itself

Abstract

The level of monoubiquitinated proliferating cell nuclear antigen (PCNA) is closely linked with DNA damage bypass to protect cells from a high level of mutagenesis. However, it remains unclear how the level of monoubiquitinated PCNA is regulated. Here, we demonstrate that human ELG1 protein, which comprises an alternative replication factor C (RFC) complex and plays an important role in preserving genomic stability, as an interacting partner for the USP1 (ubiquitin-specific protease 1)-UAF1 (USP1-associated factor 1) complex, a deubiquitinating enzyme complex for PCNA and FANCD2. ELG1 protein interacts with PCNAs that are localized at stalled replication forks. ELG1 knockdown specifically resulted in an increase in the level of PCNA monoubiquitination without affecting the level of FANCD2 ubiquitination. It is a novel function of ELG1 distinct from its role as an alternative RFC complex because knockdowns of any other RFC subunits or other alternative RFCs did not affect PCNA monoubiquitination. Lastly, we identified a highly conserved N-terminal domain in ELG1 that was responsible for the USP1-UAF1 interaction as well as the activity to down-regulate PCNA monoubiquitination. Taken together, ELG1 specifically directs USP1-UAF1 complex for PCNA deubiquitination.

Indexed as

Protein Processing, Post-TranslationalAdenosine TriphosphatasesArabidopsis ProteinsATPases Associated with Diverse Cellular ActivitiesCells, CulturedChromatinDNA-Binding ProteinsDNA DamageDNA ReplicationEndopeptidasesFanconi Anemia Complementation Group D2 ProteinHumansImmunoblottingImmunoprecipitationKidneyMutationAdenosine TriphosphatasesArabidopsis ProteinsATAD5 protein, humanATPases Associated with Diverse Cellular ActivitiesChromatinDNA-Binding ProteinsEndopeptidasesFANCD2 protein, humanFanconi Anemia Complementation Group D2 ProteinNuclear ProteinsProliferating Cell Nuclear AntigenRNA, Small InterferingUbiquitinUbiquitin-Specific ProteasesUSP1 protein, humanWDR48 protein, human

Identifiers

PMID20147293
PMCPMC2856242
OpenAlexW2016758355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.